UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 22, 2022
Accession Number:
0001140361-22-029967
Submission Type:
POS AM
CIK:
0001595893
Company Name:
Turning Point Therapeutics, Inc.
File Number:
333-238300